New screening tests look promising in struggle to achieve the goal of a pristine blood supply
This article was originally published in Clinica
Executive Summary
Delegates to this year's annual meeting of the American Association of Blood Banking (AABB) held in San Francisco last month discussed a number of pressing issues, including nucleic acid testing (NAT) for hepatitis C virus (HCV) and HIV and transfusion safety. Danielle Rydberg and Kerri Weinert, of Boston Biomedical Consultants in the US, report on the new products.